Evidence map›Paper›PMID 39968174›Full record

ArticleComputational and structural biotechnology journal2025

Identifying somatic driver mutations in cancer with a language model of the human genome.

Guangjian Zeng, Chengzhi Zhao, Guanpeng Li, Zhengyang Huang, Jinhu Zhuang, Xiaohua Liang, Xiaxia Yu, Shenying Fang

Abstract read
In one paragraph

Article in Computational and structural biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Guangjian ZengSchool of Biomedical Engineering, Shenzhen University, Shenzhen, China.
Chengzhi ZhaoSchool of Public Health and Emergency Management, Southern University of Science and Technology, Shenzhen, China.
Guanpeng LiSchool of Public Health and Emergency Management, Southern University of Science and Technology, Shenzhen, China.
Zhengyang HuangSchool of Biomedical Engineering, Shenzhen University, Shenzhen, China.
Jinhu ZhuangShenzhen Health Development Research and Data Management Center, Guangdong, China.
Xiaohua LiangDepartment of Clinical Epidemiology and Biostatistics, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing, China.
Xiaxia YuSchool of Biomedical Engineering, Shenzhen University, Shenzhen, China.
Shenying FangSchool of Public Health and Emergency Management, Southern University of Science and Technology, Shenzhen, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Somatic driver mutations play important roles in cancer and must be precisely identified to advance our understanding of tumorigenesis and its promotion and progression. However, identifying somatic driver mutations remains challenging in Homo sapiens genomics due to the random nature of mutations and the high cost of qualitative experiments. Building on the powerful sequence interpretation capabilities of language models, we propose a self-attention-based contextualized pretrained language model for somatic driver mutation identification. We pretrained the model with the Homo sapiens reference genome to equip it with the ability to understand genome sequences and then fine-tuned it for oncogene and tumor suppressor gene prediction tasks, enabling it to extract features related to driver genes from the original genome sequence. The fine-tuned model was used to obtain the mutations' carcinogenic effect characteristics to further identify whether the mutation is a driver or a passenger. Compared with other computational algorithms, our method achieved excellent somatic driver mutation identification performance on the test set, with an absolute improvement of 4.31% in AUROC over the best comparison method. The strong performance of our method indicates that it can provide new insights into the discovery of cancer drivers.

Indexed as

Cancer driversDeep learningGenome sequencingLanguage model

Identifiers

PMID39968174
PMCPMC11833646

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.